The day traders are overlooking the coming surge in earnings from CYNO's splendid acquisition of a competitor and launching of their new FDA approved tattoo removing pico lasers this year. The earnings are level right now, but will jump significantly next year and beyond. they are dominant in the cosmetic and dermatology laser medical markets and have very solid financials. Analysts have a target of $33 (50%) on CYNO while my DCF earnings models value the stock at ~$40. I am a patient retired medical device executive and expect almost a 100% return when the shortsighted day traders realize the reality of their earnings potential. Look at the forecasts for EPS just for next year alone. Do your homework.
Do you attribute recent weakness in the stock price to the acquisition of Palomar or the recent earnings report? Not sure I understand the reason for the negative sentiment? Thank you for the informative post.
The market is driven by short-term day traders that rarely do the homework to project growing markets, understand disruptive technology, or evaulate developing fundamentals. Right now the traders are behind the curve staring at the new plateau of earnings under $1 per share, not realizing that Cynosure's momentum, the growing cosmetic markets, CYNO's dominant technolgy, and the Palomar accretive acquisition will jump their EPS towards $2 per share next year and a high double digit CGR for a number of years. Doing a DCF earnings cash flow anaylsis says the stock should be in the high $30s now. The stock will surge and catch up with reality as the higher earnings start to emerge. Meanwhile the day traders will be caught short looking in their rear view mirrors. I am a retired medical device executive and financial manager. Patience and fundamentals are my virtues.